Andreessen Horowitz leads Series A round for BigHat Biosciences

BigHat Biosciences, a novel protein therapeutics company, has raised $19 million in Series A funding.

BigHat Biosciences, a novel protein therapeutics company, has raised $19 million in Series A funding. Andreessen Horowitz led the round with participation from return backers 8VC, AME Cloud Ventures and Innovation Endeavors.

Source: Press Release